BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2020-01929 A phase II, open label, single arm, single center study to evaluate pyrexia management (with or without any other cytokine release symptoms) using tocilizumab, an humanized monoclonal antibody against More ... clinical trial drugs phase 2 monocentric A Prof. Dr. Reinhard Dummer Universitätsspital Zürich Dermatologische Klinik/ Universitätsspital Zürich, Züich
Kantonale Ethikkommission Zürich 22.09.2020 Study has ended
2020-01928 Bakterielle Zusammensetzung des Mekoniums und der Brustmilch in Assoziation mit der mütterlichen Ernährung, der Schlafqualität sowie der subjektiven und objektiven Stressreaktion während der Schwanger More ... non clinical, involving persons monocentric A Prof. Dr. rer. nat. Ulrike Ehlert Universität Zürich Psychologisches Institut, Universität Zürich, Oerlikon
Kantonale Ethikkommission Zürich 01.12.2020 Study has ended
2020-01926 A retrospective study on Transanal total mesorectal excision (TaTME) versus conventional laparoscopic total mesorectal excision TME (lapTME) in mid and low rectal cancer personal data/biological material monocentric Prof Dr med Dimitri Christoforidis EOC EOC, Lugano
Comitato etico cantonale Ticino 31.08.2020 Study has ended
2020-01925 Effects of immortalized human islet-derived MSC (hISC)-conditioned medium (CM) on human beta cells personal data/biological material monocentric Pr. Anne Wojtusciszyn CHUV - Endocrinologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 28.09.2021
2020-01924 Adenovirus persistence in human T cells personal data/biological material monocentric Prof. Urs. F. Greber UZH UZH, Zurich
Kantonale Ethikkommission Zürich 25.08.2020
2020-01922 Ethics of communication & ethics in communication: An exploratory analysis of Advance Care Planning encounters clinical trial other clinical trials monocentric A Anca-Cristina Sterie Chaire de soins palliatifs gériatriques Lausanne University Hospital, Chaire de soins palliatifs gériatriques, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.10.2020 Study has ended
2020-01921 BO42864: A PHASE III, RANDOMIZED, OPEN-LABEL STUDY OF PRALSETINIB VERSUS STANDARD OF CARE FOR FIRST-LINE TREATMENT OF RET FUSION−POSITIVE, METASTATIC NON−SMALL CELL LUNG CANCER clinical trial drugs phase 3 monocentric C Dr. med. Ulrich Richter Roche Pharma (Schweiz) AG Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Zürich 06.10.2020
2020-01920 Effects of Dapagliflozin on blood volume status and vascular function
in clinically compensated heart failure patients
after an acute heart failure event.
DAPAGLIFLOZIN ON VOLUME VASCULAR OUTCOME More ...
clinical trial drugs phase 4 monocentric C Prof. Dr. med. Frank Ruschitzka University Hospital Zurich Cardiology, Zurich
Kantonale Ethikkommission Zürich 15.10.2020
2020-01919 Bronchiectasis and Microbiome: a monocentric descriptive study non clinical, involving persons monocentric A Dre Jesica Mazza Stalder CHUV - Pneumologie Centre universitaire vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 13.10.2020
2020-01918 Evaluation of the surgical method: ultrasound-guided ultra-minimalinvasive thread carpal tunnel release personal data/biological material monocentric Prof. Dirk Schaefer University hospital Basel University Hospital Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 09.10.2020
2020-01917 Effects of the SGLT2 inhibitor empagliflozin in patients with euvolemic and hypervolemic hyponatremia – a monocentric randomized double-blind placebo-controlled trial - the EMPOWER study clinical trial drugs phase 4 multicentric C Dr. Julie Refardt University Hospital Basel University Hospital Basel, Basel
Spitalzentrum Biel, Biel/Bienne
Luzerner Kantonsspital, Luzern
CHUV, Lausanne
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 07.10.2020
2020-01916 Vissuto dei famigliari durante la limitazione delle visite per il COVID-19 e percezione dell’utilità dell’incontro con i curanti dopo il decesso del proprio congiunto non clinical, involving persons monocentric A Prof. Dr. Med. Tiziano Cassina Fondazione Cardiocentro Ticino Fondazione Cardiocentro Ticino, Lugano
Comitato etico cantonale Ticino 31.08.2020 Study has ended
2020-01915 Image-guided personalized medicine in Multiple Sclerosis non clinical, involving persons monocentric A PD Dr. med. Franca Wagner Inselspital Bern Inselspital, Bern
Kantonale Ethikkommission Bern 08.12.2020
2020-01914 Sichere Type & Screen Analyse aus Verwurfsprobe des ZVK personal data/biological material monocentric Barbara Mihm Stiftung Blutspende SRK AG-SO Stiftung Blutspende SRK AG-SO, Aarau
Ethikkommission Nordwest- und Zentralschweiz EKNZ 12.08.2020 Study has ended
2020-01913 Acoustics-based drill state, screw stability and implant insertion analysis: a cadaver study deceased persons monocentric Prof. Philipp Fürnstahl Universitätsklinik Balgrist Universitätsklinik Balgrist, Zürich
Kantonale Ethikkommission Zürich 15.09.2020
2020-01912 The importance of monitoring wet AMD patients during COVID-
19 pandemic: A retrospective study of assessment of functional
and structural outcomes.
non clinical, involving persons monocentric A Dr PD Aude Ambresin Swissvisio Medical Retina Unit Swissvisio Medical retina unit, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 20.10.2020
2020-01911 Intravitreal brolucizumab in patients with exudative non-responding age-related macular degeneration switched from aflibercept non clinical, involving persons monocentric A Dr Aude Ambresin Swissvisio, medical retina unit Swissvisio Medical retina unit, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 03.11.2020
2020-01910 A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination with Systemic Corticosteroids in Subjects with Non ambulatory Duchenne Muscular Dystrophy (DMD) clinical trial drugs phase 3 monocentric C PD Dr. med. Klein Andrea FibroGen, Inc. Inselspital Universitätsspital Bern, Bern 3010
Kantonale Ethikkommission Bern 29.03.2021 yes Study has ended
2020-01909 M20-178 A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofib More ... clinical trial drugs phase 3 multicentric C PD Dr. med. Dominik Heim AbbVie AG Universitätsspital Basel, Basel
Universitätsspital Bern, Bern
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern 28.10.2021 Study has ended
2020-01908 Deliberate updating of schematic memory with new emotional experiences: An experimental demonstration non clinical, involving persons monocentric A PD Dr. Ueli Kramer CHUV - Psychiatrie Department of Psychiatry-CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 26.10.2020